Compound details
7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one
| Compound ID | CDAMM02602 |
|---|---|
| Common name | 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one | IUPAC name | 7-hydroxy-6-methoxy-3-(4-methoxyphenyl)chromen-4-one |
| Molecular formula | C17H14O5 |
| Retention time | 18.02 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 299.094 | Theoretical mz | 299.091 |
| Error | 7.44 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 8.0174 |
| Inchi key | KJGPBYUQZLUKLL-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1C(=COC2=CC(O)=C(OC)C=C21)C=3C=CC(OC)=CC3 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Isoflavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction and SEA |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction and SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction and SEA |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SEA |
| Q96KS0 | EIT6 | HIF-prolyl hydroxylase 1 | T53904 | SwissTargetPrediction |
| Q14833 | GRM4 | Metabotropic glutamate receptor 4 | T99402 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| O43451 | MGAM | Maltase-glucoamylase | T92777 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction and SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction and SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction and SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction and SEA |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction and SEA |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SwissTargetPrediction |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SwissTargetPrediction and SEA |
| P14174 | MIF | Macrophage migration inhibitory factor | T39977 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SEA |
| P21964 | COMT | Catechol O-methyltransferase (by homology) | T76904 | SEA |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P11474 | ESRRA | Estrogen-related receptor alpha | T72841 | SwissTargetPrediction |
| O95718 | ESRRB | Estrogen-related receptor beta | T42025 | SwissTargetPrediction and SEA |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SEA |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SEA |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SwissTargetPrediction and SEA |
| P18054 | ALOX12 | Arachidonate 12-lipoxygenase | T35527 | SwissTargetPrediction and SEA |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SEA |
| P08842 | STS | Steryl-sulfatase | T33489 | SwissTargetPrediction |
| Q9NR96 | TLR9 | Toll-like receptor (TLR7/TLR9) | T11451 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SEA |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SEA |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SwissTargetPrediction |
| Q02127 | DHODH | Dihydroorotate dehydrogenase | T61400 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SwissTargetPrediction and SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SwissTargetPrediction and SEA |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction and SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| P08236 | GUSB | Beta-glucuronidase | T96413 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SwissTargetPrediction |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SwissTargetPrediction |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SwissTargetPrediction and SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P30281 | CCND3 | Cyclin-dependent kinase 4/cyclin D | T72507 | SEA |
| P51511 | MMP15 | Matrix metalloproteinase 15 | T81658 | SEA |
| Q9Y478 | PRKAB1 | AMP-activated protein kinase, beta-1 subunit | T38875 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SwissTargetPrediction and SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SwissTargetPrediction and SEA |
| Q15120 | PDK3 | Pyruvate dehydrogenase kinase isoform 3 | T99029 | SEA |
| Q9Y256 | RCE1 | Prenyl protein specific protease | T10756 | SEA |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P27169 | PON1 | Serum paraoxonase/arylesterase 1 | T34562 | SwissTargetPrediction and SEA |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SEA |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| O15427 | SLC16A3 | Monocarboxylate transporter 4 | T31788 | SEA |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| P16220 | CREB1 | Cyclic AMP-responsive element-binding protein | T92098 | SEA |
| P43354 | NR4A2 | Orphan nuclear receptor NURR1 | T67163 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| Q9UK17 | KCND3 | Voltage-gated potassium channel Kv4.3 | T74500 | SEA |
| Q9GZT9 | EGLN1 | Egl nine homolog 1 | T32880 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T53904 | DI0010 | Acute disease anaemia | [ICD-11: 3A90] | Q96KS0 | EIT6 |
| T99402 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q14833 | GRM4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T92777 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O43451 | MGAM |
| T92777 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | O43451 | MGAM |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T39977 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P14174 | MIF |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T76904 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21964 | COMT |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T72841 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P11474 | ESRRA |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T33489 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P08842 | STS |
| T11451 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9NR96 | TLR9 |
| T11451 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q9NR96 | TLR9 |
| T11451 | DI0252 | Melanoma | [ICD-11: 2C30] | Q9NR96 | TLR9 |
| T11451 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9NR96 | TLR9 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T61400 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q02127 | DHODH |
| T61400 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q02127 | DHODH |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T96413 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P08236 | GUSB |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T38875 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9Y478 | PRKAB1 |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T74500 | DI0004 | Acidosis | [ICD-11: 5C73] | Q9UK17 | KCND3 |